SCHEMBL7597400

SCHEMBL7597400

CCOC(=O)Cn1c(=O)c2c(C)c(-c3ccc(OC)cc3)sc2n(Cc2ccccc2SC)c1=O

nearest known ligand 0.48

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
GNRHR P30968 11/20 0.48
EDNRB P24530 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
ADORA2B P29275 1/20 0.40
TP53 P04637 2/20 0.40
POLB P06746 1/20 0.40
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7594585 0.92 GNRHR (0.41) GNRHREDNRBMEN1KMT2AADORA2B
SCHEMBL7592330 0.92 MEN1 (0.40) GNRHRMEN1KMT2AADORA2BTP53
SCHEMBL7593828 0.91 GNRHR (0.42) GNRHREDNRBMEN1KMT2A
SCHEMBL7851488 0.91 MEN1 (0.40) GNRHRMEN1KMT2AADORA2BTP53
SCHEMBL7849577 0.91 EDNRB (0.46) GNRHREDNRBMEN1KMT2AADORA2B
SCHEMBL7597266 0.91 GNRHR (0.42) GNRHREDNRBMEN1KMT2AALDH1A1
SCHEMBL7591452 0.90 GNRHR (0.43) GNRHREDNRBMEN1KMT2A
SCHEMBL7854741 0.89 ADORA2B (0.49) MEN1KMT2AADORA2BTP53
SCHEMBL7854900 0.89 MEN1 (0.38) GNRHRMEN1KMT2AADORA2BTP53
SCHEMBL7592834 0.89 GNRHR (0.41) GNRHREDNRBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0846119-B1 THIENOPYRIMIDINE DERIVATIVES, THEIR PRODUCTION AND USE AS ENDOTHELIN ANTAGONISTS TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2002-11-13 EP disclosed
US-6140325-A HAS ENDOTHELIN ANTAGONISTIC ACTION; FOR TREATING LIVER HYPOFUNCTION, ACUTE RENAL INSUFFICIENCY, CARDIAC INFARCTION OR LIVER INSUFFICIENCY, VASOCONSTRICTION TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2000-10-31 US disclosed